Structure Therapeutics' GSBR-1290 showed a placebo-adjusted mean weight loss of 6.2% at 12 weeks, suggesting potential despite initial underwhelming results. Comparatively, Eli Lilly’s orforglipron ...

Nuvation Bio's Taletrectinib shows promising data in phase 2 trials for ROS1-positive NSCLC, outperforming current market leaders in key metrics like DOR and PFS. Despite a small target market, ...

Data sovereignty has never been more important, but it's not easy to accomplish. Organizations are weighing the need for sovereign AI platforms that allow for complete control over their data, models ...

The business world is highly competitive because many companies offer similar products and services. Businesses often wonder how to gain a competitive advantage. The answer lies in leveraging data and ...

Retailers aren’t short on data — the challenge is making sense of it at scale. To stay competitive, businesses must not only maintain a clear view of internal operations but also track key external ...

The semiconductor industry operates at the forefront of technological innovation, even as manufacturers face constant pressure to improve production yields, manage intricate supply chains, reduce ...

Let’s be honest—today’s businesses are drowning in data but starving for actionable insights. Having navigated the complexities of marketing analytics, I’ve seen firsthand how organizations struggle ...